Cargando…
Using a Modified Delphi Approach to Gain Consensus on Relevant Comparators in a Cost-Effectiveness Model: Application to Prostate Cancer Screening
OBJECTIVE: Challenges can exist when framing the decision question in a cost-effectiveness analysis, particularly when there is disagreement among experts on relevant comparators. Using prostate cancer screening and recent developments in risk stratification, early-detection biomarkers, and diagnost...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8079293/ https://www.ncbi.nlm.nih.gov/pubmed/33797744 http://dx.doi.org/10.1007/s40273-021-01009-6 |
_version_ | 1783685196927729664 |
---|---|
author | Keeney, Edna Thom, Howard Turner, Emma Martin, Richard M. Sanghera, Sabina |
author_facet | Keeney, Edna Thom, Howard Turner, Emma Martin, Richard M. Sanghera, Sabina |
author_sort | Keeney, Edna |
collection | PubMed |
description | OBJECTIVE: Challenges can exist when framing the decision question in a cost-effectiveness analysis, particularly when there is disagreement among experts on relevant comparators. Using prostate cancer screening and recent developments in risk stratification, early-detection biomarkers, and diagnostic technologies as a case study, we report a modified Delphi approach to handle decision-question uncertainty. METHODS: The study involved two rounds of anonymous online questionnaires to identify the prostate cancer screening strategies that international researchers, clinicians and decision makers felt important to consider in a cost-effectiveness model. Both purposive and snowball sampling were used to recruit experts. The questionnaire was based on a review of the literature and was piloted for language, comprehension and ease of use prior to dissemination. In Round 1, respondents indicated their preferred screening strategy (including no screening) through a series of multiple-choice questions. The responses informed a set of 13 consensus statements, which respondents ranked their agreement with on a 9-point Likert scale (Round 2). Consensus was considered reached if > 70% of participants indicated agreement and < 15% indicated disagreement. RESULTS: Twenty participants completed Round 1 and 17 completed Round 2. Consensus was shown towards comparing no formal screening, age-based, and risk-based strategies. The risk-based approaches included screening only higher-risk men, using shorter screening intervals for higher-risk men, screening higher-risk men at an earlier age, and tailoring screening intervals based on prostate-specific antigen (PSA) level at a previous test. There was agreement that inclusion of MRI in the pathway should be considered, but disagreement on the inclusion of new biomarkers. CONCLUSION: In disease areas where technologies are rapidly evolving, a modified Delphi approach provides a useful tool to identify relevant comparators in an economic evaluation. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s40273-021-01009-6. |
format | Online Article Text |
id | pubmed-8079293 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-80792932021-05-05 Using a Modified Delphi Approach to Gain Consensus on Relevant Comparators in a Cost-Effectiveness Model: Application to Prostate Cancer Screening Keeney, Edna Thom, Howard Turner, Emma Martin, Richard M. Sanghera, Sabina Pharmacoeconomics Original Research Article OBJECTIVE: Challenges can exist when framing the decision question in a cost-effectiveness analysis, particularly when there is disagreement among experts on relevant comparators. Using prostate cancer screening and recent developments in risk stratification, early-detection biomarkers, and diagnostic technologies as a case study, we report a modified Delphi approach to handle decision-question uncertainty. METHODS: The study involved two rounds of anonymous online questionnaires to identify the prostate cancer screening strategies that international researchers, clinicians and decision makers felt important to consider in a cost-effectiveness model. Both purposive and snowball sampling were used to recruit experts. The questionnaire was based on a review of the literature and was piloted for language, comprehension and ease of use prior to dissemination. In Round 1, respondents indicated their preferred screening strategy (including no screening) through a series of multiple-choice questions. The responses informed a set of 13 consensus statements, which respondents ranked their agreement with on a 9-point Likert scale (Round 2). Consensus was considered reached if > 70% of participants indicated agreement and < 15% indicated disagreement. RESULTS: Twenty participants completed Round 1 and 17 completed Round 2. Consensus was shown towards comparing no formal screening, age-based, and risk-based strategies. The risk-based approaches included screening only higher-risk men, using shorter screening intervals for higher-risk men, screening higher-risk men at an earlier age, and tailoring screening intervals based on prostate-specific antigen (PSA) level at a previous test. There was agreement that inclusion of MRI in the pathway should be considered, but disagreement on the inclusion of new biomarkers. CONCLUSION: In disease areas where technologies are rapidly evolving, a modified Delphi approach provides a useful tool to identify relevant comparators in an economic evaluation. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s40273-021-01009-6. Springer International Publishing 2021-04-02 2021 /pmc/articles/PMC8079293/ /pubmed/33797744 http://dx.doi.org/10.1007/s40273-021-01009-6 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by-nc/4.0/Open AccessThis article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
spellingShingle | Original Research Article Keeney, Edna Thom, Howard Turner, Emma Martin, Richard M. Sanghera, Sabina Using a Modified Delphi Approach to Gain Consensus on Relevant Comparators in a Cost-Effectiveness Model: Application to Prostate Cancer Screening |
title | Using a Modified Delphi Approach to Gain Consensus on Relevant Comparators in a Cost-Effectiveness Model: Application to Prostate Cancer Screening |
title_full | Using a Modified Delphi Approach to Gain Consensus on Relevant Comparators in a Cost-Effectiveness Model: Application to Prostate Cancer Screening |
title_fullStr | Using a Modified Delphi Approach to Gain Consensus on Relevant Comparators in a Cost-Effectiveness Model: Application to Prostate Cancer Screening |
title_full_unstemmed | Using a Modified Delphi Approach to Gain Consensus on Relevant Comparators in a Cost-Effectiveness Model: Application to Prostate Cancer Screening |
title_short | Using a Modified Delphi Approach to Gain Consensus on Relevant Comparators in a Cost-Effectiveness Model: Application to Prostate Cancer Screening |
title_sort | using a modified delphi approach to gain consensus on relevant comparators in a cost-effectiveness model: application to prostate cancer screening |
topic | Original Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8079293/ https://www.ncbi.nlm.nih.gov/pubmed/33797744 http://dx.doi.org/10.1007/s40273-021-01009-6 |
work_keys_str_mv | AT keeneyedna usingamodifieddelphiapproachtogainconsensusonrelevantcomparatorsinacosteffectivenessmodelapplicationtoprostatecancerscreening AT thomhoward usingamodifieddelphiapproachtogainconsensusonrelevantcomparatorsinacosteffectivenessmodelapplicationtoprostatecancerscreening AT turneremma usingamodifieddelphiapproachtogainconsensusonrelevantcomparatorsinacosteffectivenessmodelapplicationtoprostatecancerscreening AT martinrichardm usingamodifieddelphiapproachtogainconsensusonrelevantcomparatorsinacosteffectivenessmodelapplicationtoprostatecancerscreening AT sangherasabina usingamodifieddelphiapproachtogainconsensusonrelevantcomparatorsinacosteffectivenessmodelapplicationtoprostatecancerscreening |